Insider Trading July 8, 2026 07:13 PM

BillionToOne CEO Atay Oguzhan Executes $4.7M Share Sale Under Pre-Arranged Plan

Insider Activity Analysis: Executive Liquidation Amidst Strong Financial Performance and Analyst Upgrades

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
BLLN

Atay Oguzhan, Chairman and CEO of BillionToOne Inc. (NASDAQ:BLLN), executed significant transactions involving the company's Class A Common Stock on July 6, 2026, under a Rule 10b5-1 trading plan. The transactions included the sale of approximately $4.7 million in shares and the acquisition of 26,250 shares through the exercise of vested stock options. These moves occur as BillionToOne reports robust first-quarter 2026 financial results and receives an upgraded price target from Guggenheim, highlighting a period of strong company performance alongside executive liquidity events.

BillionToOne CEO Atay Oguzhan Executes $4.7M Share Sale Under Pre-Arranged Plan
BLLN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • BillionToOne reported robust first-quarter 2026 financial results, with earnings per share of $0.34 and revenue reaching $108.4 million, representing an 84% year-over-year increase.
  • Guggenheim upgraded its price target for BLLN shares from $100 to $120, citing new private payor contracting wins and improved reimbursement positioning.
  • Shareholders elected Oguzhan Atay and Akshay Rai as Class I directors at the recent annual meeting, with terms extending until the 2029 annual meeting.

MENLO PARK, CA – Atay Oguzhan, Chairman and Chief Executive Officer of BillionToOne, Inc. (NASDAQ:BLLN), executed a series of significant transactions involving the company's Class A Common Stock on July 6, 2026. According to the filing, Mr. Oguzhan sold shares valued at approximately $4,729,379 while simultaneously acquiring additional shares through the exercise of stock options. All activities were conducted under a Rule 10b5-1 trading plan, which was established on March 6, 2026.

The executive's transactions occurred as BillionToOne shares traded at $120.10, a price point that reflects a substantial 38% gain over the preceding six months. The company's market capitalization stands at $5.4 billion, implying a price-to-earnings ratio of 125. Valuation metrics suggest the stock may be trading above its fair value estimate, according to InvestingPro analysis.

Mr. Oguzhan, acting both directly and indirectly through his spouse, disposed of a total of 38,240 shares of Class A Common Stock. The sales were executed at prices ranging from $118.4866 to $124.74 per share. The transactions involved multiple trades within specified price ranges, often utilizing weighted average prices. Indirect sales, totaling 11,990 shares, are attributed to holdings controlled by Mr. Oguzhan's spouse.

Concurrently, Mr. Oguzhan acquired 26,250 shares of Class A Common Stock by exercising stock options at a price of $2.80 per share, resulting in a total transaction value of $73,500. These options were fully vested and exercisable at the time of the transaction. Following these activities, Mr. Oguzhan's direct ownership of BillionToOne Class A Common Stock stands at zero shares. His spouse's indirect ownership is 175,000 shares.

The insider activity coincides with BillionToOne reporting strong financial results for the first quarter of 2026. The company's earnings per share reached $0.34, exceeding market expectations. Revenue for the quarter rose to $108.4 million, marking an 84% increase compared to the previous year. These results reflect significant growth in both revenue and profitability for the company.

Additionally, Guggenheim raised its price target for BillionToOne shares from $100 to $120, maintaining a Buy rating. This adjustment follows discussions with BillionToOne management regarding new private payor contracting wins and improvements in the company's reimbursement position. Furthermore, during the company's recent annual meeting, shareholders elected two Class I directors, Oguzhan Atay and Akshay Rai, to serve until the 2029 annual meeting.

Investors can access comprehensive Pro Research Report on InvestingPro for deeper insights into BLLN's valuation and growth prospects.

Risks

  • Valuation concerns exist as the stock trades at a P/E ratio of 125 and may be overvalued relative to its fair value estimate.
  • Executive ownership has shifted significantly, with Mr. Oguzhan's direct ownership now at zero shares, though his spouse retains 175,000 shares.

More from Insider Trading

Evommune Director Arthur Kirsch Acquires $133,000 Stake Amid Clinical Setbacks Jul 8, 2026 Corcept Therapeutics CDO William Guyer Sells $1.86M in Stock Jul 8, 2026 Meta Platforms COO Javier Olivan Executes $3.15 Million Share Sale Under Pre-Arranged Trading Plan Jul 8, 2026 Snowflake Director Michael L Speiser Offloads $12.2M in Stock Under Pre-Arranged Plan Jul 8, 2026 Snowflake Director Michael Speiser Offloads $216K in Shares Through Pre-Arranged Plan Jul 8, 2026